You can buy or sell DTIL and other stocks, options, ETFs, and crypto commission-free!
Precision BioSciences, Inc. Common Stock, also called Precision BioSciences, is a biotechnology company, which engages in the development of genome editing technologies. Read More It operates through the Therapeutics and Food segments. The Therapeutics segment focuses on the development of products in the field of immuno-oncology and of novel products outside immuno-oncology to treat human diseases. The Food segment applies ARCUS, the company's propriety genome editing platform, to develop food and nutrition products through collaboration agreements with consumer-facing companies. The company was founded by Derek N. Jantz, Jeff Smith, and Matthew R. Kane in January 2006 and is headquartered in Durham, NC.
Durham, North Carolina
52 Week High
52 Week Low
Expected Mar 26, Pre-Market